Rumored Walmart Deal Adds Value and More to the Progressive

New Post Public Reply Private Reply Replies (0) Message Board
times2times2
1,050
Rumored Walmart Deal Adds Value and More to the Progressive Care Approach
https://smallcapvoice.com/blog/rumored-walmar...-approach/
Walmart is rumored to be going after PillPack, a start-up company that bundles pills together into convenient pouches for easy access and use. Patients are increasingly turning to convenience packaging because it allows them to know exactly what they’re supposed to take and when. PillPack is an online pharmacy offering at-home delivery, providing even more reason to stay compliant with prescribed medication. Their business is built upon improving the customer’s experience, from the beginning to the end. While it’s currently unclear if this deal will go through, sources say that Walmart is offering PillPack just under $1 billion for the company.

PillPack is just one start-up in the pharmaceutical industry trying to increase the level of patient care in response to an increasingly impersonal system. Another company making headlines in the pharmaceutical world for their unique approach and novel concepts is Progressive Care, Inc. (OTC QB: RXMD). Progressive Care, Inc., through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, and health practice risk management.

The Walmart offer for PillPack comes at a critical time for RXMD. Until recently there have been few comparable pharmacies offering services similar to PharmCo, LLC. The market cap for RXMD has ranged between $4 million and $100 million. Now that PillPack is being offered a dollar figure from Walmart, RXMD has a way to assess what their Company is worth. Walmart’s current offer is slightly less than a $1 billion, however, it is widely assumed the transaction will close around that figure. At close to $100 million in revenue nationwide, PillPack’s valuation could provide needed clarity on the value of RXMD. RXMD released audited financial statements for 2017 indicating over $20 million in sales, the bulk of which is in the South Florida area. Like PillPack, RXMD’s model is absolutely invested in the safety and well-being of their patients.

One of the main focusses for RXMD is on Medication Management Therapy, and their success is measured by their positive cash flow and $20 million in net revenues. Managed care isn’t just good for patients, but for their doctors as well. Patients look to their doctors to both prevent and heal diseases, and they’ll measure their physician based on their success. By stressing a more proactive approach to the patient, the preventative care can naturally follow. RXMD currently offers a wide range of services that center around adherence and compliance to improve patient health outcomes. Free same day and next day delivery throughout South Florida, access to a full inventory of medications including specialty and compounded drugs, risk management services to physicians, and home health assessments for patients struggling with their medication regiment are just some of the services that take RXMD’s approach to the next level.

Progressive Care Inc.’s success is also because the Company doesn’t simply react to the shifting expectations in healthcare – they actively strategize ways to anticipate and exceed consumer expectations. Finishing out a successful 2017, they managed to follow up those achievements with over 65,000 prescriptions filled in the first quarter and approximately $5 million in net revenue, a record in both respects for the Company. Their subsidiary PharmCo is operating in 13 states and RXMD has also filed applications to register in three more states. The offer to PillPack also validates RXMD’s acquisition of Touchpoint Rx, LLC a Palm Beach County, FL pharmacy with the same convenience packaging technology as PillPack. RXMD intends to roll out this service, which was previously reserved to institutional customers only, to a retail patient with local accessibility

PharmCo, LLC is also a 5-star pharmacy that makes it easier for doctors and pharmacists to work together to meet their goals. Their pharmacists are more involved in the patient’s history, so they can spot potential errors or mistakes. As doctors adopt managed care, they receive more credit for their efforts and more recognition of their own efficacy in promoting wellness. Preventative care may take a little extra effort, but it’s far more efficient than waiting until a disease is out of control. As their success grows, doctors find they’re able to hit their coveted bonuses without any additional effort aside from their standard course of care. The best way to describe Progressive Care today, in the words of its CEO, S. Parikh Mars, is “profitable, growing, and determined.”

PillPack’s story is an exciting one, which is garnering interest from giants like Walmart. Like PillPack, Progressive Care has quietly built up an infrastructure based on sustainability in an ever-changing market. The current excellence in value added services that RXMD provides above and beyond what PillPack can offer suggests that one could make the argument that Progressive Care looks like an ideal candidate for another major player to target. RXMD achieves high marks at lower operating costs, higher per employee productivity, lower customer acquisition costs, higher ratio of revenue to market size, and local integration. Now that PillPack’s story is out there, the next place to look for innovation and success in the pharmacy and healthcare space is RXMD.

Progressive Care Inc. (RXMD) Stock Research Links

RXMD Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

SOCi's MCP Push Makes Context the Product Moat Bigger

Updated Category News Views 78

Software agents without decent business context are just eager interns with access to the keyboard. SOCi’s November 19, 2026 announcement gets at that unglamorous truth: the company has made its Model Context Protocol server generally available and says its context layer now connects with more than 140 integrations. It is not a flashy new chatbot stunt. It is a bid to...

Continue Reading
Palmer Holland Takes Natural Colors Across North America

Updated Category News Views 27

Natural food color sounds like a tidy little ingredient story until somebody tries to keep a blue beverage blue on a retail shelf. That is where Palmer Holland's new exclusive North American commercial arrangement with BOTANIKind gets interesting. This is not a flashy public-market transaction, and neither company has handed investors a revenue figure, volume target, or...

Continue Reading
PBS Holiday Special Bets on Apollo 8, Music and Unity

Updated Category News Views 47

A moon mission, a 360-voice choir, and Christmas television make an unusual bundle, but that is precisely why this year’s Tabernacle Choir special has some real staying power. Peace on Earth: Christmas with The Tabernacle Choir is not trying to chase whatever noisy trend is chewing up attention this week. It is building a 90-minute holiday event around Apollo 8,...

Continue Reading
M.O.L.I.F.E. Brings Community Inclusion Into Public View

Updated Category News Views 138

A food pantry can reveal more about inclusion than a polished mission statement ever will. M.O.L.I.F.E., Inc. is set to be featured in an educational segment of All Access with Andy Garcia, and the useful part of this story is not the celebrity-host packaging. It is the organization’s insistence that employment, independent living, day programming, residential support,...

Continue Reading
Mace Consult Bets on Sawaya for Americas Expansion

Updated Category News Views 120

Concrete, tunnel bores, and data-center campuses rarely wait politely for a leadership transition. Mace Consult has named Mario Sawaya president of its Americas business, and the hire reads less like ceremonial executive shuffling than a deliberate move toward the thickest part of the capital-spending map. Sawaya brings more than 20 years of experience leading...

Continue Reading
Art Limitless Jury Puts SDG 12 and Art Into Clear Focus

Updated Category News Views 30

A paint pigment, a discarded object, and a serious climate question have landed in the same room. BE OPEN Art’s 2026 Art Limitless competition is aimed at SDG 12, the United Nations goal centered on responsible production and consumption. That may sound like institutional language built for conference folders, but the underlying issue is plain enough: society cannot...

Continue Reading
UTI Faces Fresh Scrutiny After Its Earnings Guidance Miss

Updated Category News Views 74

A Guidance Gap That Cannot Be Shrugged Off A $0.20-per-share hole is a nasty thing to find after management said it could see the road ahead. Universal Technical Institute reported fiscal 2026 diluted earnings per share of $0.60, below the $0.71 to $0.80 range it reaffirmed on May 6. That is at least $0.11 under the low end and roughly 21% below the midpoint. For...

Continue Reading
PG&E's $456 Million Interim Hike Faces a New Test Soon

Updated Category News Views 112

A utility can call a charge interim, but households still see the bill arrive in full. That is why the California Public Utilities Commission's unanimous approval of $456 million in interim rate recovery for Pacific Gas & Electric has landed with such rotten timing. The money is set to begin flowing from customers on January 1, 2027, while major questions about PG&E's...

Continue Reading
Cineverse Sets Wolf Creek Return for March 19, 2027

Updated Category News Views 121

A sunburned serial killer is heading back to theaters, and Cineverse has finally put a date on it: March 19, 2027. WOLF CRE3K, formerly called Wolf Creek: Legacy, brings John Jarratt back as Mick Taylor for the third film in the Australian horror franchise. For NASDAQ:CNVS investors, this is not the kind of announcement that lets anyone pencil in revenue with a straight...

Continue Reading
Corner Bakery Bets on Holiday Catering Convenience

Updated Category News Views 101

A $50 carrot on a $350 catering tab tells you exactly where Corner Bakery sees the holiday battlefield: not in one lonely cookie sale, but in the larger group order that can make a restaurant’s day. The chain is pushing holiday catering through November and December, pairing that discount with bakery trays, meals for groups and a promise to handle delivery setup. It is...

Continue Reading

Top 5 Most Recently Viewed Articles

Mobile Homes Market Grows to $16.62B by 2031

Updated Category News Views 24

Affordable Housing Fuels Mobile Homes Market When the traditional real estate market is out of reach, what's the average Joe supposed to do? Enter the mobile home market, which is expected to leap from $11.87 billion in 2026 to a hefty $16.62 billion by 2031. That's a compound annual growth rate (CAGR) of 6.96%—not too shabby for a sector often ignored by the mainstream...

Continue Reading
KinderCare Investors Face Legal Challenges Over IPO Misrepresentation

Updated Category News Views 213

Legal Action Against KinderCare Learning Companies A securities class action lawsuit has been initiated against KinderCare Learning Companies, Inc. (NYSE: KLC) and its executives. This lawsuit centers on allegations that the company misrepresented its activities and safety records during its Initial Public Offering (IPO) in October 2024. Investors who acquired KLC common...

Continue Reading
Intec Pharma Ltd's Stock Sees Decline: A Deeper Analysis

Updated Category News Views 204

Intec Pharma Ltd Faces a Rocky Road Intec Pharma Ltd (NASDAQ: INDP) is knee-deep in trouble, with its stock diving to a brutal 52-week low of $1.20. This stark drop of 56.12% over the past year paints a dismal picture for investors scoping out this biotech player. It’s no surprise that all eyes are on INDP as it struggles to navigate these choppy waters and rebuild its...

Continue Reading
Sol Rei Wine Shines at San Francisco Wine Competition

Updated Category News Views 190

Celebrating Excellence at the San Francisco Wine Competition In an impressive display of craftsmanship and quality, Sol Rei Wine has recently achieved remarkable accolades at the esteemed San Francisco Wine Competition. This boutique, women-owned wine brand has won both Double Gold and Gold medals for their exquisite offerings: the Sol Rei Syrah and the Sol Rei Private...

Continue Reading
Insight Molecular Diagnostics Gears Up for Exciting 2026 Launch

Updated Category News Views 260

Exciting Progress Ahead for Insight Molecular Diagnostics Inc. Insight Molecular Diagnostics Inc. (NASDAQ: IMDX) is taking significant strides towards launching its innovative GraftAssureDx™ test in 2026. With anticipation building within the organization and among stakeholders, the company is preparing to submit its application for FDA approval by the year's end. This...

Continue Reading